Hong Kong stocks with biopharmaceutical concepts led the decline in early trading, with Rongchang Biopharma (09995.HK) falling more than 5%, WuXi Biologics (02268.HK) and WuXi Biologics (02269.HK) both falling more than 4%, and InnoCare Pharma (09969

2025-07-07

Hong Kong stocks with biopharmaceutical concepts led the decline in early trading, with Rongchang Biopharma (09995.HK) falling more than 5%, WuXi Biologics (02268.HK) and WuXi Biologics (02269.HK) both falling more than 4%, and InnoCare Pharma (09969.HK), WuXi AppTec (02359.HK) and other stocks following the decline; on the news front, the U.S. "Big Beautiful Act" was passed early this morning, the bill proposes to cut healthcare spending.